Samsung Biologics
207940 · KRX · Healthcare
OpenDARTFilings checked 15 Sept 2026, 22:20 UTCFinancials checked 15 Sept 2026, 22:20 UTC
Annual reporting period: 2025-01-01 — 2025-12-31 · KRW
Annual revenue₩4.56TYear over year +0.2%
Annual net income₩1.78TConsolidated net income
Annual operating income₩2.07TConsolidated basis
Operating margin45.4%Operating income / revenue
Revenue over time
ANNUALEach bar represents annual revenue for the fiscal year ending on the stated date. Compact amounts are rounded; exact values and filings are listed below.
Company & data
삼성바이오로직스
Healthcare
Market: South Korea
Currency: KRW
DART: 00877059
A recent filing date is not a new financial period. Annual figures may remain unchanged until the next annual report, even when new current reports are filed.
How this data is calculated →Annual financials & sources
CONSOLIDATED| FISCAL END | REVENUE | NET INCOME | OPERATING INCOME | SOURCE |
|---|---|---|---|---|
| 2025-12-31 | ₩4.56T4,556,971,695,180 KRW | ₩1.78T1,784,352,060,593 KRW | ₩2.07T2,069,221,266,630 KRW | Filing ↗ |
| 2024-12-31 | ₩4.55T4,547,322,176,421 KRW | ₩1.08T1,083,315,885,986 KRW | ₩1.32T1,320,052,380,133 KRW | Filing ↗ |
| 2023-12-31 | ₩3.69T3,694,588,767,068 KRW | ₩857.69B857,691,298,384 KRW | ₩1.11T1,113,680,009,715 KRW | Filing ↗ |
Amounts use currency-specific compact units. Exact amounts appear below each rounded value. An em dash means unavailable, not zero.